{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:01:51Z","timestamp":1761487311976},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.transci.2004.10.011","type":"journal-article","created":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T12:13:18Z","timestamp":1108210398000},"page":"117-124","source":"Crossref","is-referenced-by-count":6,"title":["Estimation and predictive use of the corrected count increment\u2014a proposed clinical guideline"],"prefix":"10.1016","volume":"32","author":[{"given":"Lucille","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Jogessar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2004.10.011_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.314.7083.809","article-title":"ABC of clinical haematology: platelet disorders","volume":"314","author":"Liesner","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2004.10.011_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2004.10.011_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1423-0410.1996.tb01296.x","article-title":"Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets: comparison between platelet concentrates derived from pooled buffy coates and apheresis","volume":"70","author":"Eriksson","year":"1996","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2004.10.011_bib4","doi-asserted-by":"crossref","unstructured":"Guidelines for the use of platelet transfusions. The British Committee for Standards in Haematology, Blood Transfusion Task Force. Br J Haematol 2003;122:10\u201323","DOI":"10.1046\/j.1365-2141.2003.04468.x"},{"key":"10.1016\/j.transci.2004.10.011_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-8652(200008)64:4<251::AID-AJH3>3.0.CO;2-N","article-title":"Platelet transfusions: utilization and associated costs in a tertiary care hospital","volume":"64","author":"Meehan","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2004.10.011_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2141.1994.tb03262.x","article-title":"Influence of clinical status on the efficiency of stored platelet transfusion","volume":"86","author":"Norol","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2004.10.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1423-0410.1999.7610001.x","article-title":"Prevention and management of platelet transfusion refractoriness","volume":"76","author":"Novotny","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2004.10.011_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1423-0410.1994.tb00310.x","article-title":"Relative importance of immune and non-immune causes of platelet refractoriness","volume":"66","author":"Doughty","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2004.10.011_bib9","first-page":"356","article-title":"Platelet specific alloantigens","volume":"11","author":"Davis","year":"1998","journal-title":"Clin Lab Sci"},{"key":"10.1016\/j.transci.2004.10.011_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2007-1000377","article-title":"Clinical role of antiplatelet antibody assays","volume":"21","author":"McMillan","year":"1995","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 2","key":"10.1016\/j.transci.2004.10.011_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1423-0410.1998.tb05441.x","article-title":"Clinical aspects and typing of platelet alloantigens","volume":"74","author":"Kroll","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2004.10.011_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/tmrv.2003.50004","article-title":"Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update","volume":"17","author":"Coopamah","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2004.10.011_bib13","first-page":"265","article-title":"Detection of antiplatelet antibodies: the first hundred samples studied","volume":"13","author":"Campos","year":"2000","journal-title":"Acta Med Port"},{"key":"10.1016\/j.transci.2004.10.011_bib14","unstructured":"Jacobs P, Baker P, Martindale A, Wood L. Splenectomy: a haematologic perspective, forthcoming"},{"key":"10.1016\/j.transci.2004.10.011_bib15","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.transci.2004.10.011_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0037-1963(00)90028-3","article-title":"Current status of allogeneic bone marrow transplantation in acquired aplastic anemia","volume":"37","author":"Horowitz","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2004.10.011_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.2830360402","article-title":"Treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone","volume":"36","author":"Novitzky","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2004.10.011_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.1987.00011.x-i1","article-title":"Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases","volume":"66","author":"Klingemann","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2004.10.011_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00062752-199911000-00015","article-title":"Optimal dosing and triggers for prophylactic use of platelet transfusion","volume":"6","author":"Rinder","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.transci.2004.10.011_bib20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V81.6.1411.1411","article-title":"Platelet transfusions: the 20,000\/\u03bcL trigger","volume":"81","author":"Beutler","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.transci.2004.10.011_bib21","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10\u00d7109\/L trigger for prophylactic platelet transfusions compared with the traditional 20\u00d7109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transci.2004.10.011_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-3148.1992.tb00132.x","article-title":"The definition of refractoriness to platelet transfusions","volume":"2","author":"Bishop","year":"1992","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2004.10.011_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1537-2995.1999.39060586.x","article-title":"Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution","volume":"39","author":"Davis","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V71.2.383.383","article-title":"Clinical factors influencing the efficacy of pooled platelet transfusions","volume":"71","author":"Bishop","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.transci.2004.10.011_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0955-3886(00)00056-4","article-title":"The supply of blood products in 10 different systems or countries","volume":"22","author":"Rock","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.transci.2004.10.011_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1046\/j.1537-2995.2000.40121457.x","article-title":"Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial","volume":"40","author":"Ackerman","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.1537-2995.2000.40121425.x","article-title":"Pretransfusion testing for platelet transfusions","volume":"40","author":"Kickler","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1098-1101(1998)13:3<114::AID-JCA4>3.0.CO;2-6","article-title":"Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose","volume":"13","author":"Goodnough","year":"1998","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2004.10.011_bib29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1046\/j.1537-2995.1997.37111298088046.x","article-title":"Determination of the rate of reduction in platelet counts in recipients of hematopoietic stem and progenitor cell transplant: clinical implications for platelet transfusion therapy","volume":"37","author":"del Rosario","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0955-3886(00)00040-0","article-title":"Pharmacological therapies to minimise platelet transfusion","volume":"22","author":"Norfolk","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.transci.2004.10.011_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1537-2995.1995.35695288769.x","article-title":"Prophylactic versus therapeutic platelet transfusion practices in hematology and\/or oncology patients","volume":"35","author":"Pisciotto","year":"1995","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1537-2995.1981.21181127488.x","article-title":"Altered platelet function and circulation induced by amphotericin B in leukemia patients after platelet transfusion","volume":"21","author":"Kulpa","year":"1981","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1537-2995.1994.34594249058.x","article-title":"Guidelines for blood utilization review","volume":"34","author":"Stehling","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2004.10.011_bib34","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/bmj.307.6918.1510","article-title":"Revised guidelines on preoperative autologous blood donation","volume":"307","author":"Hambley","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2004.10.011_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/bmj.307.6901.395","article-title":"Avoiding the misuse of fresh frozen plasma","volume":"307","author":"Cohen","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2004.10.011_bib36","first-page":"57","article-title":"Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force","volume":"2","author":"Contreras","year":"1992","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2004.10.011_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2257.1996.00153.x","article-title":"The effects of a self-educating blood component request form and enforcements of transfusion guidelines on FFP and platelet usage. British Committee for Standards in Hematology (BCSH)","volume":"18","author":"Cheng","year":"1996","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.transci.2004.10.011_bib38","first-page":"27","article-title":"Guide to platelet transfusion","volume":"6","author":"Taylor","year":"1996","journal-title":"Hosp Update"},{"key":"10.1016\/j.transci.2004.10.011_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcp\/91.6.647","article-title":"Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis","volume":"91","author":"Raman","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.transci.2004.10.011_bib40","first-page":"321","article-title":"Emergency surgery and refractory immune thrombocytopenic purpura: a case report","volume":"69","author":"Jacobs","year":"1986","journal-title":"S Afr Med J"},{"key":"10.1016\/j.transci.2004.10.011_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00062752-199805000-00009","article-title":"Update on thrombopoietin in preclinical and clinical trials","volume":"5","author":"Miyazaki","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.transci.2004.10.011_bib42","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1182\/blood.V85.11.3066.bloodjournal85113066","article-title":"A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia","volume":"85","author":"Gordon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.transci.2004.10.011_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1995.tb05148.x","article-title":"A phase I\/II trial of recombinant human interleukin-6 in patients with aplastic anaemia","volume":"90","author":"Schrezenmeier","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2004.10.011_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00062752-199603030-00008","article-title":"Clinical development of recombinant human interleukin-11 to treat chemotherapy-induced thrombocytopenia","volume":"3","author":"Kaye","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.transci.2004.10.011_bib45","first-page":"3607","article-title":"A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy","volume":"87","author":"Tepler","year":"1996","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050204001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050204001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T19:30:11Z","timestamp":1586115011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050204001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1473050204001880"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2004.10.011","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}